Loading
Latest filing published 15 Oct 2026 for GSK plc, €15k. Read the official filing
Not enough history yet: 0 closed purchases, at least 2 are needed.
Maya Martinez-Davis discloses dealings in GSK plc to RNS (LSE). In total, 41 filings cover trades dated from 9 February 2026 to 13 October 2026.
In open-market terms, that means 2 purchases on one side and 5 sales worth €2.2M on the other. The totals do not cover 4 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 34 share grants.
On 15 October 2026 came the latest disclosure, a share grant for €15k in GSK plc. The latest purchase dates back some time: it was published 184 days ago, on 16 April 2026. Typically, a trade is published a median of 3 days after it takes place. The regulation allows three business days to notify a trade (UK MAR). Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
25 of 41 declarations